Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. Source link
Read More
Health care industry
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection
Read More
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
Tempus AI rose by as much as 15% on Friday after the health-care diagnostics company priced its IPO at $37,
Read More
Roche alleges counterfeit diabetes medical devices were sold on Amazon
Counterfeit diabetes test strips have been sold on Amazon and shipped to patients across the U.S., said biotech company Roche.
Read More
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their
Read More
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its
Read More
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for
Read More
Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO
Consumers' nutritional needs are "shifting" amid the rise of weight loss drugs, which is an opportunity for food companies, Nestle
Read More
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
The tracker could be a valuable tool for Americans scrambling to find GLP-1s, such as Novo Nordisk's weight loss injection
Read More